Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Randomized Open-label Controlled Study to Investigate Treatment Response of IV Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia Secondary to Inflammatory Bowel Disease or Gastric Bypass

NCT02086968 is registered in ClinicalTrials.gov with American Regent, Inc. as lead sponsor.

NCT NCT02086968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02086968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Randomized Open-label Controlled Study to Investigate Treatment Response of IV Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia Secondary to Inflammatory Bowel Disease or Gastric Bypass
Lead sponsor
American Regent, Inc.
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2014
Completion date
October 31, 2017
Enrollment
198 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency anemia secondary to ibd or gastric bypass